EPCAM and breast cancer: Besides, abnormal glycosylation has been shown to regulate signaling pathways and markers involved in conservation of CSCs, such as EpCAM glycosylation on cell adhesion (23) and EMT in breast cancer, or N-glycosylation on MAPK and PI3/Akt pathway (24).